There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
392.72 Cr.Face value
10.00Book value
704.75Div. yield
0.12%P/E ratio
19.78P/B ratio
1.84Debt/Eq.
0.43Market Cap
392.72 Cr.Face value
10.00Book value
704.75Div. yield
0.12%P/E ratio
19.78P/B ratio
1.84Debt/Eq.
0.43
| Dec 25 | Sep 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 71.80% | 71.41% | 0.39% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
SMS Lifesciences India is presently engaged in the business of manufacturing buying selling offering consultancy importing and exporting acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals Pharma Read more 
Manufactures APIs and bulk drugs across multiple therapeutic segments, backed by two prominent production units in Visakhapatnam and Hyderabad, and supported by contract research and manufacturing services (CRAMS).
Major revenue sources for FY 2024–25 include Europe (31%), North America (27%), Export Oriented Units/SEZ/Direct Exports (24%), India (12%), and Asia excluding India (6%). Regulated markets constitute nearly 88% of total revenue.
The company has one subsidiary, acquired on November 1, 2024, that supports manufacturing scale and regulatory capacities.
